Charles River Laboratories International (CRL) Other Accumulated Expenses (2009 - 2025)

Charles River Laboratories International's Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $222.2 million for Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 14.51% year-over-year to $222.2 million; the TTM figure through Dec 2025 stood at $222.2 million (up 14.51% YoY), while the FY2025 annual figure was $222.2 million, up 14.51% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $222.2 million, up from $216.0 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $222.2 million in Q4 2025, with the low at $97.3 million in Q1 2021.
• The 5-year median for Other Accumulated Expenses is $196.2 million (2024), against an average of $184.3 million.
• The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses dropped 10.63% in 2021, then surged 48.47% in 2022.
• Charles River Laboratories International's Other Accumulated Expenses stood at $140.4 million in 2021, then soared by 45.67% to $204.6 million in 2022, then declined by 0.67% to $203.2 million in 2023, then decreased by 4.53% to $194.0 million in 2024, then gained by 14.51% to $222.2 million in 2025.
• Business Quant data shows CRL's Other Accumulated Expenses at $222.2 million in Q4 2025, $216.0 million in Q3 2025, and $207.2 million in Q2 2025.